The Carcinogenic Roles of MicroRNA-613andMicroRNA-223inthe Epithelial Ovarian Cancer:APilot Study
محل انتشار: پانزدهمین کنگره بین المللی زنان و مامایی ایران
سال انتشار: 1398
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 468
نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
این مقاله در بخشهای موضوعی زیر دسته بندی شده است:
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
COBGY15_050
تاریخ نمایه سازی: 11 آبان 1398
چکیده مقاله:
It is generally accepted that ovarian cancer is the leading cause of death among womenworldwideasa most deadly cancer in the female reproductive system, and is often diagnosedatdevelopedstages.MicroRNAsplay critical roles in the initiation and progression of cancer, metastasis and resistance to different therapies as biological molecules that regulate thegene expression.Studies have found that K-RASprotein of miR-31targets is significantly important in thecarcinogenesis of ovarian cancer.The present study also aimed to compare microRNA-613andmicroRNA-223levels insample patients with ovarian cancer.Method: In this study, 25samples of malignant ovarian cancer, 25 samples of benign ovarian cysts and 5 samples of healthy ovaries were collected and stored in -700C.RNA was extracted andcomplementary DNA (cDNA) was prepared by Cdna synthesis kit. The gene expression level of MicroRNA-613 and MicroRNA-223was evaluated by Real Time PCR method. Results were analysed by SPSS21 software and one way ANOVA statistical method.Results: According to an analysis ofobtained results of Real-time PCRtechniqueby a relative method in two groups of patients with ovarian cancer and benign and malignant tumors, and a healthy group, the relative expressionof miRNA-223in samples of malignant tumors, benign tumors and healthy ovaries was 1.94, 0.64, and 1.26respectively (p= 0.01).These results indicated thatthe relative expressionof miRNA-613insamples of malignant tumor, benigntumor and healthy ovaries was 0.65, 2.13, and 1.78, respectively. (p=0.05).Conclusion: We can concludethat miRNA-613andmiRNA-223have potential for introduction as research targets in biomarker discovery studies for early diagnosis of metastasis in patients with ovarian cancer.They can also be effective in anticipating the response to treatment, and play potential roles in developing therapeutic approaches and predict treatment outcomes in ovarian cancer patients.
کلیدواژه ها:
نویسندگان
Laya Shirinzadeh
Assistant professor, Department of Obstetrics and Gynecology, Fellowship of Gynecology Oncology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran